Bausch Health Companies Inc. (BHC) — Stock Score Summary

Bausch Health Companies Inc. (BHC) has a MoatMap StockRank of 69/100 based on Quality (50/100), Value (64/100), and Momentum (39/100) factor scores. The current signal is BUY. Bausch Health is burdened by massive leverage and ongoing litigation, making it a highly speculative turnaround rather than a quality compounder.

Bausch Health Companies Inc. develops, manufactures, and markets a diverse portfolio of pharmaceutical products, with a strong presence in eye health (Bausch + Lomb), gastroenterology, and dermatology. The company maintains a significant global footprint and established brands within its therapeutic areas, particularly benefiting from its legacy Bausch + Lomb business. BHC is in a transformational phase, actively de-leveraging and streamlining its operations, including the spin-off of its eye care business.

Key Financial Metrics

Price$5.17
Market Cap$2.0B
P/E (Forward)1.28
Price/Book-0.95
Return on Invested Capital8.9%
Gross Margin71.0%
Operating Margin20.6%
Revenue Growth11.7%
Free Cash Flow$1.1B

Bausch Health Companies Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Canada).

Frequently Asked Questions

What is Bausch Health Companies Inc.’s (BHC) StockRank?
MoatMap’s StockRank for Bausch Health Companies Inc. (BHC) is 69/100, with a Buy signal. It is a composite of Quality (50), Value (64), and Momentum (39) factor ranks across MoatMap’s 19,000+ stock universe.
Does Bausch Health Companies Inc. have an economic moat?
Bausch Health Companies Inc. (BHC) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bausch Health Companies Inc. a buy, hold, or sell?
MoatMap’s current signal for Bausch Health Companies Inc. (BHC) is Buy, based on a StockRank of 69/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bausch Health Companies Inc. in?
Bausch Health Companies Inc. (BHC) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (Canada).
Browse all ranked stocksBHC deep dive reportAI ChampionsHow we score stocksSense-check another stock